PMID- 11133879 OWN - NLM STAT- MEDLINE DCOM- 20010118 LR - 20081121 IS - 0146-0404 (Print) IS - 0146-0404 (Linking) VI - 42 IP - 1 DP - 2001 Jan TI - A combination of CNTF and BDNF rescues rd photoreceptors but changes rod differentiation in the presence of RPE in retinal explants. PG - 275-82 AB - PURPOSE: To gather information regarding the combination of ciliary neurotrophic factor (CNTF) and brain-derived neurotrophic factor (BDNF), compared with the individual factors when used as a treatment to retard photoreceptor cell loss in rd mouse retina explants and to investigate the observation that the retinal pigment epithelium (RPE) influences rod differentiation by this treatment. METHODS: Postnatal day (PN)2 or PN7 control and rd mouse retinas were grown with attached retinal pigment epithelium (RPE). The explants were kept in culture up to PN28. During this culture period CNTF, BDNF, CNTF+BDNF, or vehicle were continuously administered to the culture medium. The nontrophic factors cyclosporin A and N:-CBZ-aspartic acid-glutamic acid-valine-aspartic acid-fluoromethyl ketone (z-DEVD-fmk) were also used. The number of photoreceptor nuclei remaining in the outer nuclear layer (ONL) was analyzed in hematoxylin and eosin-stained sections. Rod- and cone-specific antibodies were used to determine identity and state of differentiation of the photoreceptors. RESULTS: Compared with vehicle treatment, BDNF or CNTF resulted in 1.4- or 2-fold more surviving cell rows in the ONL, respectively. However, when CNTF and BDNF were applied together, surviving ONL cell counts in the rd explants were approximately 3 times those in vehicle-treated explants. In the presence of CNTF or CNTF+BDNF, opsin and arrestin expression in rods was decreased compared with rods without attached RPE. Cyclosporin A and z-DEVD-fmk did not show rescue of rd photoreceptor cells. CONCLUSIONS: CNTF or BDNF treatment of rd retinal explants delays photoreceptor cell loss to some extent. However, when these agents are combined, photoreceptor rescue is much more effective. The quenching of opsin and arrestin expression caused by treatment suggests that simultaneous with rod rescue, rod differentiation is depressed. Regarding retinal degeneration, the results from the selective inhibitors of apoptosis rank the CNTF+BDNF combination treatment as the most consistent and effective experimental pharmacologic intervention currently available. FAU - Caffe, A R AU - Caffe AR AD - Department of Zoology, Goteborg University, Sweden. FAU - Soderpalm, A K AU - Soderpalm AK FAU - Holmqvist, I AU - Holmqvist I FAU - van Veen, T AU - van Veen T LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (Arrestin) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Ciliary Neurotrophic Factor) RN - 0 (Rod Opsins) SB - IM MH - Animals MH - Apoptosis/drug effects MH - Arrestin/metabolism MH - Brain-Derived Neurotrophic Factor/*therapeutic use MH - Cell Differentiation/*drug effects MH - Cell Survival/drug effects MH - Ciliary Neurotrophic Factor/*therapeutic use MH - Coculture Techniques MH - Drug Therapy, Combination MH - Immunoenzyme Techniques MH - Mice MH - Mice, Inbred C3H MH - Organ Culture Techniques MH - Photoreceptor Cells, Vertebrate/drug effects MH - Pigment Epithelium of Eye/*pathology MH - Retinal Degeneration/*drug therapy/metabolism/pathology MH - Retinal Rod Photoreceptor Cells/metabolism/*pathology MH - Rod Opsins/metabolism EDAT- 2001/01/03 11:00 MHDA- 2001/02/28 10:01 CRDT- 2001/01/03 11:00 PHST- 2001/01/03 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2001/01/03 11:00 [entrez] PST - ppublish SO - Invest Ophthalmol Vis Sci. 2001 Jan;42(1):275-82.